Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacqueline Tate

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Paediatric Drugs|February 2, 2018
Rotavirus Vaccines: Effectiveness, Safety, and Future DirectionsEleanor Burnett, Umesh Parashar, Jacqueline Tate
Expert Review of Vaccines|June 17, 2020
An overview of rotavirus vaccination programs in developing countriesBenjamin D Hallowell, Jacqueline Tate, Umesh Parashar
Human Vaccines|July 13, 2010
Performance of rotavirus vaccines in developed and developing countriesVictoria Jiang, Baoming Jiang, Jacqueline Tate, et al.
Vaccine|December 3, 2020
Safety profile of rotavirus vaccines among individuals aged ≥8 months of age, United States, vaccine adverse event reporting system (VAERS), 2006-2019Penina Haber, Jacqueline Tate, Paige L Marquez, et al.
Transactions of the American Clinical and Climatological Association|January 11, 2013
The control of rotavirus gastroenteritis in the United StatesRoger I Glass, Umesh Parashar, Manish Patel, et al.
Vaccine|April 24, 2012
Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030Deborah E Atherly, Kristen D C Lewis, Jacqueline Tate, et al.
Plos Medicine|October 31, 2012
Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysisManish M Patel, Andrew D Clark, Colin F B Sanderson, et al.
The Lancet. Global Health|April 23, 2021
Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling studyFrédéric Debellut, Andrew Clark, Clint Pecenka, et al.
The Lancet. Infectious Diseases|June 11, 2019
Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trialsAndrew Clark, Kevin van Zandvoort, Stefan Flasche, et al.
The Pan African Medical Journal|September 22, 2021
Age distribution and mortality associated with intussusception in children under two years of age in nine sentinel surveillance hospitals in Zambia, 2007-2018Evans Mwila Mpabalwani, Bruce Bvulani, Julia Simwaka, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Paediatric Drugs|February 2, 2018
Rotavirus Vaccines: Effectiveness, Safety, and Future DirectionsEleanor Burnett, Umesh Parashar, Jacqueline Tate
Expert Review of Vaccines|June 17, 2020
An overview of rotavirus vaccination programs in developing countriesBenjamin D Hallowell, Jacqueline Tate, Umesh Parashar
Human Vaccines|July 13, 2010
Performance of rotavirus vaccines in developed and developing countriesVictoria Jiang, Baoming Jiang, Jacqueline Tate, et al.
Vaccine|December 3, 2020
Safety profile of rotavirus vaccines among individuals aged ≥8 months of age, United States, vaccine adverse event reporting system (VAERS), 2006-2019Penina Haber, Jacqueline Tate, Paige L Marquez, et al.
Transactions of the American Clinical and Climatological Association|January 11, 2013
The control of rotavirus gastroenteritis in the United StatesRoger I Glass, Umesh Parashar, Manish Patel, et al.
Vaccine|April 24, 2012
Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030Deborah E Atherly, Kristen D C Lewis, Jacqueline Tate, et al.
Plos Medicine|October 31, 2012
Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysisManish M Patel, Andrew D Clark, Colin F B Sanderson, et al.
The Lancet. Global Health|April 23, 2021
Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling studyFrédéric Debellut, Andrew Clark, Clint Pecenka, et al.
The Lancet. Infectious Diseases|June 11, 2019
Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trialsAndrew Clark, Kevin van Zandvoort, Stefan Flasche, et al.
The Pan African Medical Journal|September 22, 2021
Age distribution and mortality associated with intussusception in children under two years of age in nine sentinel surveillance hospitals in Zambia, 2007-2018Evans Mwila Mpabalwani, Bruce Bvulani, Julia Simwaka, et al.
Pageof 4